NASDAQ:PRTO

Proteon Therapeutics Stock Insider Trading

etoro logo Buy PRTO
*Your capital is at risk
$27.88
-0.0562 (-0.201%)
At Close: Jun 03, 2026

Proteon Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 26.7M and sold 73.04M PRTO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 26.7M shares
Sell 73.04M shares
71% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 30, 2017
Buy
Common Stock
A-Award
Kowalsky Matthew Paul
Vp, Legal And Secretary
Officer 10 000
Value: $13.0K
Jun 22, 2017
Buy
Series A Convertible Preferred Stock
P-Purchase
Tvm Life Science Ventures Vi Gmbh & Co Kg
Director 372
Value: $370
Jun 22, 2017
Buy
Series A Convertible Preferred Stock
P-Purchase
Haines Timothy
Director 2 526
Value: $3K
Jun 20, 2017
Buy
Stock Option (Right to Buy)
A-Award
Hastings Paul J
Director
Director 6 666
Value: $9K
Jun 20, 2017
Buy
Stock Option (Right to Buy)
A-Award
Canute Scott A
Director
Director 6 666
Value: $9K
Jun 20, 2017
Buy
Stock Option (Right to Buy)
A-Award
Haines Timothy
Director 6 666
Value: $9K
Jun 20, 2017
Buy
Stock Option (Right to Buy)
A-Award
Birner Hubert
Director 6 666
Value: $9K
Apr 27, 2017
Buy
Common Stock, $0.001 par value
Kowalsky Matthew Paul
Vp, Legal And Secretary
Officer 0
Value: $0
Apr 27, 2017
Buy
Stock Option (Right to Buy)
Kowalsky Matthew Paul
Vp, Legal And Secretary
Officer 58 431
Value: $119.8K
Apr 27, 2017
Buy
Stock Option (Right to Buy)
Kowalsky Matthew Paul
Vp, Legal And Secretary
Officer 50 000
Value: $358.0K
Jan 24, 2017
Buy
Stock Option (Right to Buy)
A-Award
Gottlieb Daniel Philip
Vp Corporate Development
Officer 29 215
Value: $59.9K
Oct 18, 2016
Buy
Stock Option (Right to Buy)
A-Award
Hastings Paul J
Director
Director 13 333
Value: $120.0K
Oct 18, 2016
Buy
Common Stock, $0.001 par value
Hastings Paul J
Director
Director 0
Value: $0
Jun 09, 2016
Buy
Stock Option (Right to Buy)
A-Award
Birner Hubert
Director 6 666
Value: $39.3K
Jun 09, 2016
Buy
Stock Option (Right to Buy)
A-Award
Haines Timothy
Director 6 666
Value: $39.3K
Jun 09, 2016
Buy
Stock Option (Right to Buy)
A-Award
Canute Scott A
Director
Director 6 666
Value: $39.3K
Dec 31, 2015
Buy
Common Stock
A-Award
Gottlieb Daniel Philip
Vp Corporate Development
Officer 244
Value: $3K
Dec 08, 2015
Buy
Stock Option (Right to Buy)
A-Award
Gottlieb Daniel Philip
Vp Corporate Development
Officer 22 000
Value: $323.4K
Jul 21, 2015
Buy
Stock Option (Right to Buy)
A-Award
Canute Scott A
Director
Director 13 333
Value: $243.3K
Jul 21, 2015
Buy
Common Stock
J-Other
Canute Scott A
Director 0
Value: $0
Jul 07, 2015
Sell
Common Stock
S-Sale
Gottlieb Daniel Philip
Vp Marketing & Bus Development
Officer 1 965
Value: $33.1K
Jun 30, 2015
Buy
Common Stock
A-Award
Gottlieb Daniel Philip
Vp Marketing & Bus Development
Officer 1 965
Value: $17.4K
Jun 02, 2015
Buy
Stock Option (Right to Buy)
A-Award
Kobyzev Dmitry
Director 6 666
Value: $117.3K
Jun 02, 2015
Buy
Stock Option (Right to Buy)
A-Award
Haines Timothy
Director 6 666
Value: $117.3K
Jun 02, 2015
Buy
Stock Option (Right to Buy)
A-Award
Birner Hubert
Director 6 666
Value: $117.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PROTEON THERAPEUTICS INC.
Proteon Therapeutics
Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular diseases. It develops vonapanitase, a recombinant human elastase, which is in two Phase III clinical trials in patients with chronic kidney disease undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis; has completed a Phase I/II clinical trials ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE